9.200USD-9.45%Mkt Cap: 812.73M USDP/E: —Last update: 2026-06-01
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral sma…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap812.73M USD
Enterprise Value348.95M USD
Revenue (TTM)71.64M USD
Gross Profit67.42M USD
Net Income (TTM)-278.67M USD
Revenue/Share0.8140 USD
Last Price9.200 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees260
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.00
PEG—
EV/EBITDA-1.10
EV/Revenue4.87
P/S12.64
P/B8.40
EPS (TTM)-3.35
EPS (Forward)-2.55
52W Range
5.45053% of range12.49
52W High12.49 USD
52W Low5.450 USD
Profitability
Gross Margin99.92%
Oper. Margin-431.51%
EBITDA Margin0.00%
Profit Margin-412.95%
ROE-160.03%
ROA-37.74%
Growth
Revenue Growth29.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-64.06M USD
CapEx (TTM)6.64M USD
FCF Margin-181.23%
FCF Yield-15.97%
Net Debt-556.55M USD
Net Debt/EBITDA1.76
Balance Sheet
Debt/Equity0.12
Current Ratio6.15
Quick Ratio5.86
Book Value/Sh1.215 USD
Cash/Share6.543 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)31.17 USD
Target Range15.00 USD – 76.00 USD
# Analysts12
Ownership
Shares Out.88.77M
Float70.26M
Insiders1.43%
Institutions96.39%
Short Interest
Short Ratio11.7d
Short % Float18.09%
Short % Out.17.62%
Shares Short15.64M
Short (prev mo.)15.01M
Technical
SMA 509.112 (+1.0%)
SMA 2009.235 (-0.4%)
Beta0.32
S&P 52W Chg27.94%
Avg Vol (30d)1.57M
Avg Vol (10d)2.51M
Technical Indicators
RSI (14)55.3
MACD0.3581
MACD Signal0.3244
MACD Hist.+0.0337
BB Upper11.16 USD
BB Middle9.767 USD
BB Lower8.376 USD
BB Width28.48%
ATR (14)0.5571 USD
Vol Ratio (20d)0.66x